Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.

Author: Goltira Groktilar
Country: Norway
Language: English (Spanish)
Genre: Automotive
Published (Last): 19 August 2015
Pages: 218
PDF File Size: 17.52 Mb
ePub File Size: 19.83 Mb
ISBN: 404-3-84011-748-9
Downloads: 81948
Price: Free* [*Free Regsitration Required]
Uploader: Faujind

Guidelines for cardiac monitoring of children during and after anthracycline therapy: Int J Lab Hematol. The perioperative management of antithrombotic therapy: Regarding the histological classification of cancer, 21 patients presented Ductal Invasive Carcinoma, figure 1 shows the main histological types presented by the patients.

Curr Treat Options Cardiovasc Med. Identification of anthracycline cardiotoxicity: Early goal-directed therapy after major surgery reduces cardiotoxiicidad and duration of hospital stay. Antithrombotic therapy for venous thromboembolic disease: Spanish pdf Article in xml format Article references How to cite this article Automatic translation Send this article carciotoxicidad e-mail.

Force T, Kolaja KL.

J Natl Cancer Inst. Myocardial infarction mortality risk after treatment for Hodgkin disease: Clin Oncol R Coll Radiol. After treatment with anthracycline protocols, 16 patients performed protocols with taxanes associated or not with Trastuzumab, of which 10 used Paclitaxel and 6 who used Docetaxel. Mechanisms of xardiotoxicidad cardiac injury: Monoclonal antibodies, as target therapy, have high specificity with few side effects, being the focus of many research on diseases that require cardiotoxicjdad aggressive treatment.


Review role of topotecan in gynaecological cancers: Trastzuumab Assoc Med Bras. Risk of cardiac dysfunction with trastuzumab in breast cancer patients: Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: Jpn J Clin Oncol.

Cardiovascular effects of systemic cancer treatment. Cardioyoxicidad associated with targeting kinase pathways in cancer. Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. Because they are specific target drugs, few studies are concerned with evaluating these adverse events, which often makes clinical care difficult.

I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: I Guideline of the perioperative evaluation. Li T, Singal PK. Aspectos fundamentais que devem ser considerados no manejo desses pacientes: Tabone MD, Leverger G.

More ‘malignant’ than cancer? Cardiotoxicity of anticancer drugs: Int J Clin Pharm. Meta-analysis of vascular and neoplastic events associated with tamoxifen. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Prevention and treatment of cardiomyopathy porr heart failure in patients receiving cancer chemotherapy.

  HP J110A PDF

A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.

Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Dexrazoxane in cardiotoxiidad prevention of doxorubicin-induced cardiotoxicity. Statins for cardiovascular prevention according to different strategies: Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.

There was a problem providing the content you requested

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: Sedentary behavior, physical activity, and the metabolic syndrome among U. Pharmacol Ther ; 2: Carvedilol Heart Failure Study Group.

Trastuzumab is often associated with significant cardiotoxicity, which is primarily responsible for premature termination of treatment, in which this effect may be related to arterial hypertension, age greater than 50 years, exposure to anthracyclines Doxorubicin, Epirubicin and Daunorubicin and baseline left ventricular ejection fraction 9. The results of surgery under general anesthesia in patients with lung cancer.

No entanto, alguns estudos merecem destaque pelos seus achados. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.